CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH Some of the key findings of this meta-analysis of antiviral therapy in the outpatient setting include: (treatment vs no-treatment)
- Probable reduction of hospitalization with Nirmatrelvir–ritonavir and casirivimab–imdevimab (1% vs 6%)
- Probable reduction in all-cause mortality with Nirmatrelvir–ritonavir (0% vs 1%)
- Probable improved recovery with regdanvimab (87% vs 72%)
- Four-day reduction in time to recovery with casirivimab-imdevimab
- Possible reduction in recovery rates with hydroxychloroquine
